CM Life Sciences $CMLF is a #SPAC still seeking target. I'm long from near NAV because I like the team very much and find the space exciting. Life sciences and genomics industry will birth some monster stocks in coming years. As #synbio unicorns come public I hope they catch one.

Link to $CMLF website is https://cmlifesciencesspac.com/ 

$CMLF is sponsored by Casdin @cascapital, a preeminent venture investor in the space. Their private investments listed on their website: https://casdincapital.com/venture/ 

Their portfolio included @908Devices which just went public as $MASS and @CloverHealth which is about to merge with $IPOC. Many others of note.

One more I will note is Flatiron @flatironhealth, an amazing company recently acquired by @Roche.

A couple monsters in the making already public in the space include $TWST and $NVTA. These pick and shovel plays in #genomics and #synbio are core holdings in $ARKG.

The board of $CMLF assisting Casdin includes the CEOs of $TWST, $NVTA, and Flatiron. It also includes esteemed investors from HFs Corvex and Third Point.

With this pedigree I am interested to see who they land. I reiterate that #SPACs still hunting for target don't make much sense above NAV (~$10) unless you're in for sentiment swing or very long term. I use to park cash near NAV with upside optionality.

Keep in mind that it's being discovered and has run up a bit. These tend to have high factor beta and "breathe" with some market cyclicality. Personally I'm comfortable with position I've accumulated and would only add on dips.

While I don't really want to "promote" this at I'd rather see it go down than up in short term, I do want to give back by putting on the radar of those that might be interested. My tweets are not advice; always do your own diligence

cc @DavidNLefkowitz